caffeine has been researched along with Hypertension, Malignant in 3 studies
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, M | 1 |
Kohno, M | 1 |
Murakawa, K | 1 |
Horio, T | 1 |
Yokokawa, K | 1 |
Yasunari, K | 1 |
Fukui, T | 1 |
Takeda, T | 1 |
Deuster, PA | 1 |
Bockman, EL | 1 |
Muldoon, SM | 1 |
1 review available for caffeine and Hypertension, Malignant
Article | Year |
---|---|
Calcium-induced calcium release in skeletal muscle.
Topics: Animals; Caffeine; Calcium; Calcium Signaling; Electrophysiology; Humans; Hypertension, Malignant; M | 2009 |
2 other studies available for caffeine and Hypertension, Malignant
Article | Year |
---|---|
Plasma immunoreactive endothelin-1 in experimental malignant hypertension.
Topics: Aging; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Blood Urea Nitrogen; Body Weig | 1991 |
In vitro responses of cat skeletal muscle to halothane and caffeine.
Topics: Animals; Caffeine; Cats; Dantrolene; Dose-Response Relationship, Drug; Electric Stimulation; Halotha | 1985 |